Fatigue in adults with Osteogenesis Imperfecta

Arjan G J Harsevoort, Koert Gooijer, Fleur S van Dijk, Daniëlle A F M van der Grijn, Anton A M Franken, Anne Marieke V Dommisse, Guus J M Janus, Arjan G J Harsevoort, Koert Gooijer, Fleur S van Dijk, Daniëlle A F M van der Grijn, Anton A M Franken, Anne Marieke V Dommisse, Guus J M Janus

Abstract

Background: Osteogenesis Imperfecta (OI) is characterized by bone fragility, and features such as blue sclerae, dentinogenesis imperfecta, hearing loss, ligamentous laxity and short stature can be present. It has long been assumed that the functional ability and quality of life of patients with OI depends primarily on the severity of skeletal deformities. However, fatigue is often mentioned in clinic by patients with all types of OI as an important modifier of their quality of life and does not always seem to be related to their functional ability. The aim of this study is to investigate whether adults with Osteogenesis Imperfecta are significantly more fatigued than the normal population.

Methods: The Fatigue Severity Scale (FSS) was distributed by mobile phone application among 151 adult patients with different OI types. Results of the FSS in the OI group were compared with two control populations from America (n = 20) and the Netherlands (n = 113).

Results: Ninety-nine patients (OI type 1 (n = 72), OI type 3 (n = 13), OI type 4 (n = 14) completed the FSS questionnaire. The mean FSS score of this cohort was 4.4 and significantly higher than the control populations (2.3/2.9). 65% of our cohort reported at least moderate fatigue compared with 2 control populations from America and the Netherlands.

Conclusion: Fatigue in patients with OI is a frequently encountered problem in our expert clinic but research into this topic is sparse. This pilot study is the largest study to date investigating fatigue in patients with OI and results have been compared with two control groups. The mean FSS score of 4.4 in the OI group indicates that people with OI are generally significantly more fatigued than the control population. Further evaluation of fatigue and its influencers in a larger group of OI patients is important for future management.

Keywords: Fatigue; Fatigue severity scale; Osteogenesis Imperfecta.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
FSS score per age with marking of moderate and high fatigue scores according to Krupp et al

References

    1. Steiner RD, Basel D. COL1A1/2 Osteogenesis Imperfecta. [Updated 2019 Dec 12]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2005. p. 1993–2019.
    1. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101–116. doi: 10.1136/jmg.16.2.101.
    1. Van Dijk FSS, Sillence DOO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet Part A. 2014;164:1470–1481. doi: 10.1002/ajmg.a.36545.
    1. Rauch F, Glorieux F. Ostegenesis Imperfecta. Lancet. 2004;363(9418):1377–85.
    1. Glorieux FH. Osteogenesis imperfecta. Best Pract Res Clin Rheumatol. 2008;22:85–100. doi: 10.1016/j.berh.2007.12.012.
    1. Van Dijk FS, Byers PH, Dalgleish R, Malfait F, Maugeri A, Rohrbach M, Symoens S, Sistermans EA, Pals G. EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta. Eur J Hum Genet. 2012;(1):11–9.
    1. Hill Claire L, Baird Wendy O, Walters Stephen J. Quality of life in children and adolescents with Osteogenesis Imperfecta: a qualitative interview based study. Health and Quality of Life Outcomes. 2014;12(1):54. doi: 10.1186/1477-7525-12-54.
    1. Tosi LL, Oetgen ME, Floor MK, Huber MB, Kennelly AM, McCarter RJ, Rak MF, Simmonds BJ, Simpson MD, Tucker CA, McKiernan FE. Initial report of the osteogenesis imperfecta adult natural history initiative. Orphanet J Rare Dis. 2015;10:146.
    1. Arponen H, Waltimo-Sirén J, Valta H, Mäkitie O. Fatigue and disturbances of sleep in patients with osteogenesis imperfecta - A cross-sectional questionnaire study. BMC Musculoskelet Disord. 2018;19(1):3.
    1. Van Brussel M, Takken T, Uiterwaal CSPM, Pruijs HJ, Van der Net J, Helders PJM, Engelbert RHH. Physical Training in Children with Osteogenesis Imperfecta. J Pediatr. 2008;152:111–116. doi: 10.1016/j.jpeds.2007.06.029.
    1. Finsterer J, Mahjoub SZ. Fatigue in healthy and diseased individuals. Am J Hosp Palliat Med. 2014;31:562–575. doi: 10.1177/1049909113494748.
    1. Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res. 2004;56:157–170. doi: 10.1016/S0022-3999(03)00371-4.
    1. Whitehead L. The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manag. 2009;37:107–128. doi: 10.1016/j.jpainsymman.2007.08.019.
    1. Krupp Lauren B. The Fatigue Severity Scale. Archives of Neurology. 1989;46(10):1121. doi: 10.1001/archneur.1989.00520460115022.
    1. Merkies I. S. J., Schmitz P. I. M., Samijn J. P. A., van der Meche F. G. A., van Doorn P. A. Fatigue in immune-mediated polyneuropathies. Neurology. 1999;53(8):1648–1648. doi: 10.1212/WNL.53.8.1648.
    1. Scheres LJJ, van Dijk FS, Harsevoort AJ, van Dijk ATH, Dommisse AM, Janus GJM, Franken AAM. Adults with osteogenesis imperfecta: clinical characteristics of 151 patients with a focus on bisphosphonate use and bone density measurements. Bone Reports Elsevier. 2018;8:168–172. doi: 10.1016/j.bonr.2018.04.009.
    1. Pouchot Jacques, Kherani Raheem B., Brant Rollin, Lacaille Diane, Lehman Allen J., Ensworth Stephanie, Kopec Jacek, Esdaile John M., Liang Matthew H. Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. Journal of Clinical Epidemiology. 2008;61(7):705–713. doi: 10.1016/j.jclinepi.2007.08.016.
    1. Goligher EC, Pouchot J, Brant R, Kherani RB, Aviña-Zubieta JA, Lacaille D, Lehman AJ, Ensworth S, Kopec J, Esdaile JM, Liang MH. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol. 2008;35(4):635–42.
    1. Lerdal Anners, Wahl Astrid K., Rustoen Tone, Hanestad Berit R., Moum Torbjorn. Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scandinavian Journal of Public Health. 2005;33(2):123–130. doi: 10.1080/14034940410028406.
    1. Valko Philipp O., Bassetti Claudio L., Bloch Konrad E., Held Ulrike, Baumann Christian R. Validation of the Fatigue Severity Scale in a Swiss Cohort. Sleep. 2008;31(11):1601–1607. doi: 10.1093/sleep/31.11.1601.
    1. Hald JD, Folkestad L, Harsløf T, Brixen K, Langdahl B. Health-related quality of life in adults with Osteogenesis Imperfecta. Calcif Tissue Int Springer US. 2017;101:473–478. doi: 10.1007/s00223-017-0301-4.
    1. Bathen Trine, Velvin Gry, Rand-Hendriksen Svend, Robinson Hilde Stendal. Fatigue in adults with Marfan syndrome, occurrence and associations to pain and other factors. American Journal of Medical Genetics Part A. 2014;164(8):1931–1939. doi: 10.1002/ajmg.a.36574.
    1. Mueller B, Engelbert R, Baratta-Ziska F, Bartels B, Blanc N, Brizola E, Fraschini P, Hill C, Marr C, Mills L, Montpetit K, Pacey V, Molina MR, Schuuring M, Verhille C, de Vries O, Yeung EHK, Semler O. Consensus statement on physical rehabilitation in children and adolescents with osteogenesis imperfecta. Orphanet J Rare Dis BioMed Central. 2018;13:158. doi: 10.1186/s13023-018-0905-4.
    1. Dalgas U., Stenager E., Jakobsen J., Petersen T., Hansen HJ, Knudsen C., Overgaard K., Ingemann-Hansen T. Fatigue, mood and quality of life improve in MS patients after progressive resistance training. Multiple Sclerosis Journal. 2010;16(4):480–490. doi: 10.1177/1352458509360040.
    1. Neill Jane, Belan Ingrid, Ried Karin. Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review. Journal of Advanced Nursing. 2006;56(6):617–635. doi: 10.1111/j.1365-2648.2006.04054.x.
    1. Peters KF, Kong F, Horne R, Francomano CA, Biesecker BB. Living with Marfan syndrome I. Perceptions of the condition. Clinical Genetics. 2002;60(4):273–282. doi: 10.1034/j.1399-0004.2001.600405.x.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera